De pulmonale fordele, der blev observeret hos patienter, omfattede en klinisk betydelig forbedring af FVC på 35% hos 1 patient og signifikante reduktioner i antal timer med ventilatorstøtte hos 2 patienter.
The pulmonary benefits observed in patients included a clinically meaningful improvement in FVC of 35% in one patient, and significant reductions in the number of hours of ventilator support needed in 2 patients.